CXCL9 and acute coronary syndrome: While reduced Cxcl9 expression similarly indicates suppressed myocardial inflammatory response, patients with acute coronary syndrome show decreased peripheral blood levels of this chemokine—likely due to monocyte recruitment to infarct zones, where CXCL9 serves as a potent chemoattractant [45].